ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #948Top JournalHybrid

Journal of Controlled Release

Acronym:corel
•
Abbreviation (ISO):J. CONTROLLED RELEASE
•
Identifier (ISSN):0168-3659(Print)/1873-4995(Online)
•
Publisher:Elsevier
Clarivate IF (2026)
12.4↑ +0.9
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Controlled Release

WoS Q1
5912167.8820187.920197.7320209.78202111.5202210.8202310.5202411.5202512.42026
Annual Impact Factor Metric
Current (2026):12.4
Scopus SJR & RankScopus Q1
2.535
#948

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
345

345 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate3.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
676articles/year
23.26% Gold OA•70.45% Original Research

Aims & Scope

The Journal of Controlled Release (JCR) publishes high-quality research articles in the broad field of delivery science and technology. This includes drug delivery systems and all aspects of formulations, such as physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development in the disciplines of pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries. Manuscripts that advance fundamental understanding of principles and/or demonstrate advantages of novel technologies in safety and efficacy over current clinical standards will be given priority. Each issue has the cover story highlighting the significance of a selected article published in the issue. At the end of each quarter, the JCR editors select "The Editors' Choice" from the published research articles.

Topics Covered (Recognized by AI)
Chemistry89.4%Biology81.6%Medicine73.9%Biochemistry63%Genetics61.7%Materials science60.9%Organic chemistry58.8%Physics53%Engineering47.1%Nanotechnology45.4%Pharmacology44.7%Internal medicine43.7%Chemical engineering37.7%Quantum mechanics30.3%Psychology28.4%Drug delivery27.2%Composite material26.6%Nuclear magnetic resonance26%Psychiatry24.5%Biotechnology21.6%In vitro21.5%Drug21.2%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CHEMISTRY, MULTIDISCIPLINARY

Q1
Rank26/250
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank12/356
IndexSCIE
JCISCIE2026

CHEMISTRY, MULTIDISCIPLINARY

Q1
Rank15/251
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank13/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF12.4
Articles / Year773
Total Citations858
2025
IF11.5
Articles / Year1,168
Total Citations10,983
2024
IF10.5
Articles / Year862
Total Citations19,122
2023
IF10.8
Articles / Year738
Total Citations24,563
2022
IF11.467
Articles / Year739
Total Citations37,140

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #948Scopus Q1SCImago Profile
Scopus Coverage:1984-2026
Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
2.535

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
12.87

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,838 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations28,829
3-Year Documents2,034
Citable Documents2,010

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区CHEMISTRY, MULTIDISCIPLINARY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Controlled Release (acronym: corel, abbr: J. CONTROLLED RELEASE, ISSN: 0168-3659) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier in Netherlands since 1984. The periodical holds a Journal Impact Factor (JIF) of 12.4, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.535 (Q1), an H-index of 345.

The journal enforces rigorous peer evaluation with an average review speed of 6.2周, a publication frequency of Semimonthly, an annual output of approximately 676 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,838 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier
Publication Language
English
Frequency
Semimonthly
Founding Year
1984
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: c69308d7-a167-497b-aeee-c88a0c9142eb
Database Updated: 2026-10-01